Correlation Between Unicycive Therapeutics and Mereo BioPharma
Can any of the company-specific risk be diversified away by investing in both Unicycive Therapeutics and Mereo BioPharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Unicycive Therapeutics and Mereo BioPharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Unicycive Therapeutics and Mereo BioPharma Group, you can compare the effects of market volatilities on Unicycive Therapeutics and Mereo BioPharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Unicycive Therapeutics with a short position of Mereo BioPharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Unicycive Therapeutics and Mereo BioPharma.
Diversification Opportunities for Unicycive Therapeutics and Mereo BioPharma
-0.68 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Unicycive and Mereo is -0.68. Overlapping area represents the amount of risk that can be diversified away by holding Unicycive Therapeutics and Mereo BioPharma Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mereo BioPharma Group and Unicycive Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Unicycive Therapeutics are associated (or correlated) with Mereo BioPharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mereo BioPharma Group has no effect on the direction of Unicycive Therapeutics i.e., Unicycive Therapeutics and Mereo BioPharma go up and down completely randomly.
Pair Corralation between Unicycive Therapeutics and Mereo BioPharma
Given the investment horizon of 90 days Unicycive Therapeutics is expected to generate 1.57 times more return on investment than Mereo BioPharma. However, Unicycive Therapeutics is 1.57 times more volatile than Mereo BioPharma Group. It trades about 0.23 of its potential returns per unit of risk. Mereo BioPharma Group is currently generating about -0.04 per unit of risk. If you would invest 38.00 in Unicycive Therapeutics on September 12, 2024 and sell it today you would earn a total of 42.00 from holding Unicycive Therapeutics or generate 110.53% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Unicycive Therapeutics vs. Mereo BioPharma Group
Performance |
Timeline |
Unicycive Therapeutics |
Mereo BioPharma Group |
Unicycive Therapeutics and Mereo BioPharma Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Unicycive Therapeutics and Mereo BioPharma
The main advantage of trading using opposite Unicycive Therapeutics and Mereo BioPharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Unicycive Therapeutics position performs unexpectedly, Mereo BioPharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mereo BioPharma will offset losses from the drop in Mereo BioPharma's long position.Unicycive Therapeutics vs. Transcode Therapeutics | Unicycive Therapeutics vs. Cardio Diagnostics Holdings |
Mereo BioPharma vs. Terns Pharmaceuticals | Mereo BioPharma vs. PDS Biotechnology Corp | Mereo BioPharma vs. Inozyme Pharma | Mereo BioPharma vs. Hookipa Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Other Complementary Tools
CEOs Directory Screen CEOs from public companies around the world | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |